Hyperpolarization - Description, Overview & Method
Peder Eric Zufall Larson1

1Radiology and Biomedical Imaging, University of California - San Francisco, San Francisco, CA, United States

Synopsis

The goal of this educational session is to provide understanding of the basic principles of generating hyperpolarization and hyperpolarized MR imaging strategies, which have enabled novel in vivo imaging studies of metabolism, perfusion, pH, ventilation, redox state, and more. This talk will cover hyperpolarization methods, including those used in clinical trials, and imaging strategies that efficiently use the non-recoverable magnetization.

Highlights

  • Hyperpolarization provides substantial sensitivity enhancements
  • Enables novel in vivo imaging of metabolism, perfusion, pH, redox state, and more
  • Description of hyperpolarization methods, including methods used in clinical trials
  • Description of hyperpolarized imaging strategies that efficiently use the non-recoverable magnetization
  • Slides will be posted at: http://radiology.ucsf.edu/research/labs/larson/educational-materials

Target Audience

Imaging scientists and physicians with interests in imaging methods based on hyperpolarized agents.

Outcomes/Objectives

The goal of this educational session is to provide understanding of the basic principles of generating hyperpolarization and hyperpolarized MR imaging strategies.

Purpose

Hyperpolarization provides substantial sensitivity enhancements that enables many new in vivo imaging contrasts and information, including metabolism, perfusion, pH, redox state, and more. Hyperpolarization is particularly beneficial for non-proton nuclei, which suffer from low concentration and/or natural abundance that limits sensitivity. Following administration of hyperpolarized agents, tailored MRS and MRI strategies allow for in vivo studies.

Methods

Experiment

A hyperpolarized MRI experiment typically consists of

  1. Preparation of the agent
  2. Hyperpolarization of the agent
  3. Administration to the subject
  4. Imaging acquisition

This presentation will focus on the hyperpolarization and acquisition components.

Hyperpolarization

There are several approaches that can provide hyperpolarization, each with their own unique requirements and tradeoffs. This talk will focus on dissolution dynamic nuclear polarization (dDNP), which is currently in human metabolic imaging studies at multiple sites, and will also discuss other approaches:

  • Dissolution dynamic nuclear polarization (dDNP) [1, 2]: In this approach, a sample containing the agent and an electron spin source is irradiated with microwaves to transfer the electron polarization to the nuclear spins. This is typically done at low temperatures (down to <1K) to further increase the polarizations. Since the sample is frozen, it must be rapidly dissolved prior to administration and imaging. The most common use of dDNP is for hyperpolarization of 13C nuclei for metabolic imaging.
  • Parahydrogen induced polarization (PHIP) [3]: These methods exploit the spin order of the parahydrogen (pH2) singlet state, which can be transferred to nuclei of interest including 13C and 15N. PHIP methods are typically fast and cheap relative to dDNP, but the range of polarizable compounds of in vivo interest is currently limited. New methods including SABRE [4] and SABRE-SHEATH [5] have greatly expanded the capabilities of PHIP.
  • Optical Pumping: Spin-exchange optical pumping [6] has been used to hyperpolarize 3He and 129Xe gasses, both of which have been translated into human pulmonary imaging studies [7]. Circularly polarized laser light is used to excite electrons in an alkali metal, which transfers polarization to the nuclei.

Imaging Methods

MR with hyperpolarized agents require specialized imaging method that address the unique challenges of hyperpolarized agents, including non-recoverable and rapid signal decay, rapid uptake, and metabolic conversion [8]. For example, hyperpolarized [1-13C]pyruvate experiments must be completed within approximately 1-2 minutes due to T1 decay, and must separately resolve metabolic products of lactate, alanine, and bicarbonate based on their chemical shift.

1. RF pulse strategies: RF pulses for hyperpolarized MR should be designed to efficiently use the limited available magnetization and, if needed, for selective excitation of different metabolites.

  • Variable flip angles: The RF flip angles are typically increased during the experiment to compensate for the effect of the preceding RF pulses T1 decay and metabolic conversion [9].
  • Multiband strategies: In the presence of metabolic conversion, lower excitation flip angles of the hyperpolarized substrate preserve magnetization and improve the SNR of metabolic products [10].
  • Spectral-spatial RF pulses: These pulses can achieve both spatial localization and spectral selectively of various hyperpolarized compounds [11].

2. Acquisition strategies: Acquisition methods must capture the rapid dynamics of administered hyperpolarized agents, which are rapidly modulated (on the order of seconds) due to uptake, conversion, and T1 decay. They also must often capture spectral information to resolve various hyperpolarized compounds.

  • MRSI: Rapid MRSI methods, such as echo-planar spectroscopic imaging (EPSI) [12] and spiral CSI [13] are useful to provide spectral coverage.
  • Model-based approaches: With known chemical shifts, model-based approaches such as IDEAL [14 ]are faster than MRSI.
  • Fast Imaging methods: Single resonance experiments can use fast imaging methods, such as spirals or EPI. With sparse chemical shifts, these fast imaging techniques can be used in combination with metabolite-specific spectral-spatial excitations [15].
  • Acceleration methods: Parallel imaging [16–18] and compressed sensing [19] have been shown to provide beneficial accelerations for hyperpolarized MRI for either more rapid imaging or increased spatial coverage.

3. Data Analysis: Many hyperpolarized MR experiments use kinetic models for quantification of metabolic conversion, uptake, and perfusion [20–25].

Discussion

Hyperpolarization of [1-13C]pyruvate via dDNP and 129Xe gas via optical pumping are currently in multi-site human studies, applied to cancer, heart disease, neurological disorders, and pulmonary diseases. Commercial polarizers and multi-nuclear RF coils are currently available for other sites to get into this area of research. The use of other hyperpolarization methods and other agents is a very active area of research, as is the development of new acquisition and analysis methods, and will evolve rapidly in the coming years along with the exploration of the clinical applications of hyperpolarized MR.

Acknowledgements

No acknowledgement found.

References

1. Ardenkjær-Larsen JH, Fridlund B, Gram A, Hansson G, Hansson L, Lerche MH, Servin R, Thaning M, Golman K. Increase in signal-to-noise ratio of > 10,000 times in liquid-state NMR. Proc Natl Acad Sci U S A. 2003;100(18):10158–63.

2. Ardenkjaer-Larsen JH, Leach AM, Clarke N, Urbahn J, Anderson D, Skloss TW. Dynamic nuclear polarization polarizer for sterile use intent. NMR in Biomedicine. 2011;24(8):927–932.

3. Bowers C. Transformation of Symmetrization Order to Nuclear-Spin Magnetization by Chemical Reaction and Nuclear Magnetic Resonance". Phys. Rev. Lett.; Physical Review Letters. 1986;57(21):2645--2648.

4. Adams RW, Aguilar JA, Atkinson KD, Cowley MJ, Elliott PIP, Duckett SB, Green GGR, Khazal IG, López-Serrano J, Williamson DC. Reversible Interactions with para-Hydrogen Enhance NMR Sensitivity by Polarization Transfer. Science. 2009;323(5922):1708–1711.

5. Theis T, Truong ML, Coffey AM, Shchepin RV, Waddell KW, Shi F, Goodson BM, Warren WS, Chekmenev EY. Microtesla SABRE Enables 10% Nitrogen-15 Nuclear Spin Polarization. Journal of the American Chemical Society. 2015;137(4):1404–1407.

6. Walker TG, Happer W. Spin-exchange optical pumping of noble-gas nuclei. Reviews of Modern Physics. 1997;69(2):629–642.

7. Mugler JP 3rd, Driehuys B, Brookeman JR, Cates GD, Berr SS, Bryant RG, Daniel TM, de Lange EE, Downs JH 3rd, Erickson CJ, et al. MR imaging and spectroscopy using hyperpolarized 129Xe gas: preliminary human results. Magn Reson Med. 1997;37(6):809–15.

8. Gordon JW, Larson PEZ. Pulse Sequences for Hyperpolarized MRS. In: eMagRes. John Wiley & Sons, Ltd; 2007.

9. Zhao L, Mulkern R, Tseng C-H, Williamson D, Patz S, Kraft R, Walsworth RL, Jolesz FA, Albert MS. Gradient-Echo Imaging Considerations for Hyperpolarized 129Xe MR. J Magn Reson B. 1996;113(2):179–183.

10. Larson PEZ, Kerr AB, Chen AP, Lustig MS, Zierhut ML, Hu S, Cunningham CH, Pauly JM, Kurhanewicz J, Vigneron DB. Multiband excitation pulses for hyperpolarized 13C dynamic chemical-shift imaging. J Magn Reson. 2008;194(1):121–7.

11. Larson P, Shang H, Kerr A. agentmess/Spectral-Spatial-RF-Pulse-Design: Version 1.1. Zenodo. [accessed 2017 Mar 31]. https://zenodo.org/record/439542

12. Yen Y-F, Kohler SJ, Chen AP, Tropp J, Bok R, Wolber J, Albers MJ, Gram KA, Zierhut ML, Park I, et al. Imaging considerations for in vivo 13C metabolic mapping using hyperpolarized 13C-pyruvate. Magn Reson Med. 2009;62(1):1–10.

13. Mayer D, Levin YS, Hurd RE, Glover GH, Spielman DM. Fast metabolic imaging of systems with sparse spectra: application for hyperpolarized 13C imaging. Magn Reson Med. 2006;56(4):932–7.

14. Wiesinger F, Weidl E, Menzel MI, Janich MA, Khegai O, Glaser SJ, Haase A, Schwaiger M, Schulte RF. IDEAL spiral CSI for dynamic metabolic MR imaging of hyperpolarized [1-13C]pyruvate. Magn Reson Med. 2012;68(1):8–16.

15. Cunningham CH, Chen AP, Lustig M, Hargreaves BA, Lupo J, Xu D, Kurhanewicz J, Hurd RE, Pauly JM, Nelson SJ, et al. Pulse sequence for dynamic volumetric imaging of hyperpolarized metabolic products. J Magn Reson. 2008;193(1):139–146.

16. Arunachalam A, Whitt D, Fish K, Giaquinto R, Piel J, Watkins R, Hancu I. Accelerated spectroscopic imaging of hyperpolarized C-13 pyruvate using SENSE parallel imaging. NMR\ Biomed. 2009;22(8):867–873.

17. Shin PJ, Larson PEZ, Ohliger MA, Elad M, Pauly JM, Vigneron DB, Lustig M. Calibrationless parallel imaging reconstruction based on structured low-rank matrix completion. Magn Reson Med. 2014;72(4):959–70.

18. Ohliger MA, Larson PEZ, Bok RA, Shin P, Hu S, Tropp J, Robb F, Carvajal L, Nelson SJ, Kurhanewicz J, et al. Combined parallel and partial fourier MR reconstruction for accelerated 8-channel hyperpolarized carbon-13 in vivo magnetic resonance Spectroscopic imaging (MRSI). J Magn Reson Imaging. 2013;38(3):701–13.

19. Hu S, Lustig M, Balakrishnan A, Larson PEZ, Bok R, Kurhanewicz J, Nelson SJ, Goga A, Pauly JM, Vigneron DB. 3D compressed sensing for highly accelerated hyperpolarized (13)C MRSI with in vivo applications to transgenic mouse models of cancer. Magn Reson Med. 2010;63(2):312–21.

20. Bahrami N, Swisher CL, Von Morze C, Vigneron DB, Larson PEZ. Kinetic and perfusion modeling of hyperpolarized (13)C pyruvate and urea in cancer with arbitrary RF flip angles. Quant Imaging Med Surg. 2014;4(1):24–32.

21. Bankson JA, Walker CM, Ramirez MS, Stefan W, Fuentes D, Merritt ME, Lee J, Sandulache VC, Chen Y, Phan L, et al. Kinetic Modeling and Constrained Reconstruction of Hyperpolarized [1-13C]-Pyruvate Offers Improved Metabolic Imaging of Tumors. Cancer Res. 2015;75(22):4708–17.

22. Hill DK, Orton MR, Mariotti E, Boult JKR, Panek R, Jafar M, Parkes HG, Jamin Y, Miniotis MF, Al-Saffar NMS, et al. Model free approach to kinetic analysis of real-time hyperpolarized 13C magnetic resonance spectroscopy data. PLoS One. 2013;8(9):e71996.

23. Khegai O, Schulte RF, Janich MA, Menzel MI, Farrell E, Otto AM, Ardenkjaer-Larsen JH, Glaser SJ, Haase A, Schwaiger M, et al. Apparent rate constant mapping using hyperpolarized [1-(13)C]pyruvate. NMR Biomed. 2014;27(10):1256–65.

24. Harrison C, Yang C, Jindal A, DeBerardinis RJ, Hooshyar MA, Merritt M, Dean Sherry A, Malloy CR. Comparison of kinetic models for analysis of pyruvate-to-lactate exchange by hyperpolarized 13 C NMR. NMR Biomed. 2012;25(11):1286–94.

25. Kazan SM, Reynolds S, Kennerley A, Wholey E, Bluff JE, Berwick J, Cunningham VJ, Paley MN, Tozer GM. Kinetic modeling of hyperpolarized (13)C pyruvate metabolism in tumors using a measured arterial input function. Magn Reson Med. 2013;70(4):943–53.

Proc. Intl. Soc. Mag. Reson. Med. 25 (2017)